David Geller Email and Phone Number
David Geller work email
- Valid
- Valid
- Valid
- Valid
- Valid
David Geller personal email
My experiences as a physician, clinical researcher, aerosol scientist and Pharma medical director have culminated in my current position at Arcturus, where the team is dedicated to making a significant positive impact on the health of children and adults with cystic fibrosis and other rare respiratory and metabolic diseases.
-
Vp Pulmonary And Rare DiseasesArcturus Therapeutics Dec 2020 - PresentSan Diego, Ca, UsArcturus Therapeutics a leading clinical-stage messenger RNA medicines company focused on the development of significant opportunities in respiratory and rare diseases. Arcturus has extensive experience in the discovery and development of mRNA medicines and vaccines, and design and utilization of lipid-mediated drug delivery systems. Current programs include an mRNA therapeutic for the urea cycle defect, ornithine transcarbamylase (OTC) deficiency, and an inhaled mRNA replacement strategy targeting cystic fibrosis.
-
Medical DirectorAbbvie Mar 2014 - May 2020North Chicago, Illinois, UsI led a committed and engaged clinical strategy team at AbbVie to develop transformational combination therapies for cystic fibrosis patients. In this role, I managed cross-functional interactions between Clinical Development and discovery, preclinical sciences, CMC, Medical Affairs and Commercial functions. I led the clinical strategy team including safety, pk, regulatory and statistics in designing and executing innovative clinical trials for the challenging clinical research landscape, and managed relationships with other stakeholders in the community including CF physicians, patient organizations and research networks. -
Associate Clinical ProfessorFlorida State University School Of Medicine 2005 - 2014Tallahassee, Fl, UsOrlando campus. -
Medical Consultant, Acting Medical DirectorKalobios Inc Mar 2012 - Aug 2013Protocol development and execution for Phase II development of monoclonal antibodies for severe asthma and cystic fibrosis. -
Medical ConsultantBiotech, Pharma, And Device Companies Mar 1994 - Mar 2012Scope of work includes aerosol delivery issues, protocol design (Phase I-IV), strategies to improve clinical trial enrollment, and messaging for marketing and education for providers and patients. Consulting for Mpex Pharmaceuticals in 2004 led to our lab characterizing aerosol devices for their formulations, designing and executing the Phase I study, and later our CF Center leading enrollment for the successful completion of Phase II and III studies of inhaled levofloxacin. I also advised and encouraged Pathogenesis (now Novartis) to develop TOBI as a dry-powder formulation using Pulmosphere technology. We were high recruiters in the clinical trials that led to TOBI Podhaler approval in the U.S., Canada, and several other countries., reducing the treatment burden for thousands of patients worldwide.
-
Director, Aerosol Research Lab And Cystic Fibrosis CenterNemours Children’S Clinic, Orlando Mar 1997 - Feb 2012The aerosol research lab was set up with the chief goal of understanding and improving the delivery of inhaled medications, with major emphasis on children. Since I was the director of both the 'basic science' aerosol lab as well as the Cystic Fibrosis Center, we were able to do several translation studies for inhaled therapeutics in an attempt to improve lung targeting and reduce the treatment burden of CF and other respiratory diseases. I was honored to be able to translate 'aerosol speak' to a more digestible form for patients, caregivers and clinicians through a series of publications and lectures at regional, national and global venues. During my tenure as CF Center Director, we also engaged in dozens of clinical research trials, and we were often the global leaders in enrollment for these studies. The reward was the successful launch of several new therapies for the unmet needs of cystic fibrosis. -
Associate Clinical ProfessorUniversity Of Central Florida - College Of Medicine Jul 2008 - 2012Orlando, Florida, Us
David Geller Skills
David Geller Education Details
-
University Of ArizonaPediatric Pulmonology Fellowship Program -
UclaPediatrics Residency Program
-
University Of Iowa Roy J. And Lucille A. Carver College Of MedicineMd
-
Washington University In St. LouisGeneral
Frequently Asked Questions about David Geller
What company does David Geller work for?
David Geller works for Arcturus Therapeutics
What is David Geller's role at the current company?
David Geller's current role is VP Pulmonary and Rare Diseases at Arcturus Therapeutics.
What is David Geller's email address?
David Geller's email address is da****@****vie.com
What schools did David Geller attend?
David Geller attended University Of Arizona, Ucla, University Of Iowa Roy J. And Lucille A. Carver College Of Medicine, Washington University In St. Louis.
What skills is David Geller known for?
David Geller has skills like Clinical Trials, Clinical Research, Biotechnology, Pharmaceutical Industry, Clinical Development, Medical Devices, Pediatrics, Medicine, Drug Delivery, Asthma, Cystic Fibrosis, Pharmaceutics.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial